Drugs / FK962
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00087724 | Jul 2004 → Sep 2006 | Alzheimer disease | Astellas Pharma Inc | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FK962 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00087724 ↗ |
| Modality | Small molecule | — CHEMBL4303387 ↗ |